Omada Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	189.67	169.8	122.78	89.19
Revenue Growth (YoY)	-	38.29%	37.67%	-
Cost of Revenue	72.24	66.92	52.81	46.39
Gross Profit	117.43	102.88	69.97	42.79
Selling, General & Admin	115.65	110.61	102.23	88.97
Research & Development	35.83	35.92	33.74	26.17
Operating Expenses	151.49	146.53	135.97	115.14
Operating Income	-34.06	-43.65	-66	-72.35
Interest Expense	-4.45	-4.51	-4.71	-4.2
Interest & Investment Income	0.82	0.81	5.78	2.2
Other Non Operating Income (Expenses)	0.07	0.22	-1.05	1.83
EBT Excluding Unusual Items	-37.62	-47.14	-65.98	-72.52
Other Unusual Items	-	-	-1.54	-
Pretax Income	-37.62	-47.14	-67.51	-72.52
Net Income	-37.62	-47.14	-67.51	-72.52
Net Income to Common	-37.62	-47.14	-67.51	-72.52
Shares Outstanding (Basic)	8	8	7	7
Shares Outstanding (Diluted)	8	8	7	7
Shares Change (YoY)	-	8.89%	4.59%	-
EPS (Basic)	-4.76	-6.10	-9.52	-10.70
EPS (Diluted)	-4.76	-6.10	-9.52	-10.70
Free Cash Flow	-30.38	-34.78	-50.15	-69.7
Free Cash Flow Per Share	-3.84	-4.50	-7.07	-10.28
Gross Margin	61.91%	60.59%	56.99%	47.98%
Operating Margin	-17.96%	-25.71%	-53.75%	-81.12%
Profit Margin	-19.83%	-27.76%	-54.98%	-81.31%
Free Cash Flow Margin	-16.02%	-20.48%	-40.85%	-78.15%
EBITDA	-29.05	-38.85	-61.55	-68.02
EBITDA Margin	-15.31%	-22.88%	-50.13%	-76.27%
D&A For EBITDA	5.01	4.8	4.45	4.33
EBIT	-34.06	-43.65	-66	-72.35
EBIT Margin	-17.96%	-25.71%	-53.75%	-81.12%
Revenue as Reported	189.67	169.8	122.78	89.19
Advertising Expenses	-	0.5	0.8	0.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q